Product
Long-course chemoradiation
1 clinical trial
1 indication
Indication
Locally Advanced Rectal CancerClinical trial
Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced Phase II Randomized Controlled Clinical Study of Middle and Low Rectal CancerStatus: Recruiting, Estimated PCD: 2024-11-01